Alpha Tau Medical Ltd.
DRTS
$3.48
$0.061.75%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 20.48% | 11.74% | -1.13% | -15.48% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 6.56% | 3.33% | 10.85% | -2.55% | |
| Operating Income | -6.56% | -3.33% | -10.85% | 2.55% | |
| Income Before Tax | -36.42% | -28.78% | 15.01% | 2.28% | |
| Income Tax Expenses | 2,066.67% | -75.00% | -88.46% | -95.24% | |
| Earnings from Continuing Operations | -37.25% | -28.66% | 15.23% | 2.52% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -37.25% | -28.66% | 15.23% | 2.52% | |
| EBIT | -6.56% | -3.33% | -10.85% | 2.55% | |
| EBITDA | -6.92% | -3.35% | -10.89% | 2.90% | |
| EPS Basic | -19.15% | -27.57% | 15.87% | 3.21% | |
| Normalized Basic EPS | -18.51% | -27.69% | 15.62% | -- | |
| EPS Diluted | -19.15% | -27.57% | 15.87% | 3.21% | |
| Normalized Diluted EPS | -18.51% | -27.69% | 15.62% | -- | |
| Average Basic Shares Outstanding | 15.15% | 0.82% | 0.79% | 0.73% | |
| Average Diluted Shares Outstanding | 15.15% | 0.82% | 0.79% | 0.73% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |